Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Sanara MedTech Inc. (WNDM)
|
Add to portfolio |
|
|
|
| Price: |
$27.00
| | Metrics |
| OS: |
8.52
|
M
| |
|
|
| Market cap: |
$230
|
M
| |
|
|
|
Net cash:
|
$9.14
|
M
| |
$1.07
|
per share
|
|
EV:
|
$221
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($10.2)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 45.8 | 24.1 | 15.6 | 11.8 | 5.8 | 6.3 | 5.5 | 3.4 |
| Revenue growth | 89.9% | 54.9% | 32.5% | 101.6% | -7.4% | 14.5% | 63.3% | 28.1% |
| Cost of goods sold | 6.4 | 2.3 | 1.6 | 1.2 | 0.5 | 0.8 | 0.9 | 0.9 |
| Gross profit | 39.5 | 21.8 | 14.0 | 10.6 | 5.3 | 5.5 | 4.6 | 2.5 |
| Gross margin | 86.1% | 90.4% | 89.6% | 89.7% | 91.3% | 87.2% | 82.9% | 73.5% |
| Selling, general and administrative | 46.0 | 28.1 | | | | | | |
| Research and development | 3.4 | 0.6 | | | | | | |
| General and administrative | | | 18.7 | 13.1 | 5.7 | 5.3 | 4.8 | 3.4 |
| EBITA | -10.6 | -7.6 | -4.8 | -2.7 | -0.5 | 0.1 | -0.3 | -1.0 |
| EBITA margin | -23.2% | -31.5% | -30.9% | -22.5% | -8.6% | 1.9% | -4.9% | -28.6% |
| Amortization of intangibles | 2.0 | 0.4 | 0.2 | 0.1 | | | | |
| EBIT | -12.6 | -8.0 | -5.0 | -2.7 | -0.5 | 0.1 | -0.3 | -1.0 |
| EBIT margin | -27.5% | -33.1% | -32.3% | -23.3% | -8.6% | 1.9% | -4.9% | -28.6% |
| Pre-tax income | -13.9 | -8.0 | -4.4 | -2.8 | -0.6 | 0.3 | -0.4 | -1.3 |
| Income taxes | -5.8 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 41.9% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -7.9 | -7.9 | -4.4 | -2.8 | -0.7 | 0.2 | -0.7 | -1.6 |
| Net margin | -17.3% | -32.8% | -27.9% | -23.9% | -12.5% | 3.1% | -12.3% | -47.7% |
| |
| Diluted EPS | ($1.00) | ($1.08) | ($0.78) | ($1.33) | $0.00 | $0.00 | ($0.01) | ($0.02) |
| Shares outstanding (diluted) | 7.9 | 7.3 | 5.7 | 2.1 | 217.2 | 208.6 | 108.6 | 106.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|